Compare · WLFC vs ZBH
WLFC vs ZBH
Side-by-side comparison of Willis Lease Finance Corporation (WLFC) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- WLFC operates in Consumer Discretionary, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $16.88B, about 11.9x WLFC ($1.42B).
- ZBH has been more active in the news (15 items in the past 4 weeks vs 14 for WLFC).
- ZBH has more recent analyst coverage (25 ratings vs 0 for WLFC).
- Company
- Willis Lease Finance Corporation
- Zimmer Biomet Holdings Inc.
- Price
- -
- -
- Market cap
- $1.42B
- $16.88B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 1996
- News (4w)
- 14
- 15
- Recent ratings
- 0
- 25
Willis Lease Finance Corporation
Willis Lease Finance Corporation operates as a lessor and servicer of commercial aircraft and aircraft engines worldwide. The company operates through two segments, Leasing and Related Operations, and Spare Parts Sales. The Leasing and Related Operations segment engages in acquiring and leasing commercial aircraft, aircraft engines, and other aircraft equipment, as well as the purchase and resale of commercial aircraft engines and other aircraft equipment, and other related businesses. The Spare Parts Sales segment purchases and resells after-market engine parts, whole engines, engine modules, and portable aircraft components. Willis Lease Finance Corporation was founded in 1985 and is headquartered in Coconut Creek, Florida.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest WLFC
- SEC Form DEFA14A filed by Willis Lease Finance Corporation
- Four Tree Island Advisory Highlights Overwhelming Stockholder Rejection of Willis Lease Finance's Governance and Compensation Practices at 2026 Annual Meeting
- SEC Form DEFA14A filed by Willis Lease Finance Corporation
- Amendment: Director Barrington Colm was granted 674 shares, increasing direct ownership by 10% to 7,546 units (SEC Form 4)
- Amendment: Director Curran Brendan was granted 674 shares, increasing direct ownership by 8% to 9,546 units (SEC Form 4)
- Amendment: Director Jones Stephen Francis was granted 674 shares, increasing direct ownership by 46% to 2,133 units (SEC Form 4)
- SEC Form DEFA14A filed by Willis Lease Finance Corporation
- SEC Form 8-K filed by Willis Lease Finance Corporation
- Director Barrington Colm was granted 3,000 shares, increasing direct ownership by 44% to 9,872 units (SEC Form 4)
- Director Curran Brendan was granted 3,000 shares, increasing direct ownership by 34% to 11,872 units (SEC Form 4)
Latest ZBH
- SEC Form 4 filed by Officer Noor Jehanzeb
- Group President, Asia Pacific Yi Sang sold $413,216 worth of shares (5,000 units at $82.64), decreasing direct ownership by 16% to 27,251 units (SEC Form 4)
- Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form SD filed by Zimmer Biomet Holdings Inc.
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Bernard Betsy J
- SEC Form 4 filed by Director Hilado Maria Teresa
- SEC Form 4 filed by Director Shapiro Louis
- SEC Form 4 filed by Director Kurdikar Devdatt